PATENT CLAIM ANALYSIS

Application Number: 16059909
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "265100"]

Abstract:
The disclosure is directed to compounds of Formula I Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.

Claim (Index 15):
The compound according to  claim 5 , or a pharmaceutically acceptable salt thereof, wherein said compound is\n (2R,3S,4R,5R)-5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-((R)-(4-fluoro-3-(trifluoromethyl)phenyl)(hydroxy)methyl)-3-methyltetrahydrofuran-3,4-diol.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.29167
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15045679', '15612030', '14982127', '12310597', '12903554']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8083390472117238
- 35 USC 102 Novelty (BERT): 0.5549520831706706
- Combined Prediction Score: 0.7830003508076184
- Mean Citation Score: 329.233022
- Max Citation Score: 414.93246
- Similarity Product: 385.4889824155927

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test